Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 5Lung Neoplasms 4Hematologic Neoplasms 4Hematopoietic and Lymphatic System Neoplasm 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Colorectal Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Neoplastic Syndromes, Hereditary 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Motor Activity 1Malignant Solid Neoplasm 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Hodgkin Disease 1Hematopoietic and Lymphoid System Neoplasm 1HIV Infections 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1

Interventions

Cisplatin 180Radiotherapy 81Paclitaxel 80Brachytherapy 74Carboplatin 72pembrolizumab 63Bevacizumab 40Surveys and Questionnaires 29Colposcopy 29Radiation 28Gemcitabine 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 27Topotecan 26Magnetic Resonance Spectroscopy 24Blood Specimen Collection 23human papillomavirus vaccine, L1 type 16, 18 22Nivolumab 22Drug Therapy 21Papillomavirus Vaccines 20atezolizumab 19Platinum 19Radiotherapy, Intensity-Modulated 18Biopsy 18Docetaxel 17Taxes 16Cyclophosphamide 16Early Intervention, Educational 151,2-diaminocyclohexaneplatinum II citrate 15Methods 14fludarabine 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Health Promotion × Clear all
NCT06666192 2025-12-24

The Ohio State University (OSU) SCREEN Community Program

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
2,067 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Colorectal Neoplasms

NCT04821297 2025-04-29

Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results

Thomas Jefferson University

Phase NA Completed
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡